Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. Fodil S, Chevret S, Rouzaud C, Valade S, et al. PLoS One 2022;17:e0270744.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fodil S, Chevret S, Rouzaud C, Valade S, et al. Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. PLoS One 2022;17:e0270744.
PMID: 35797337